TRASYLOL 500,000KIU/50mL injection vial

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

aprotinin, Quantity: 10000 KIU/mL

Available from:

Link Medical Products Pty Ltd T/A Link Pharmaceuticals

INN (International Name):

Aprotinin

Pharmaceutical form:

Injection, intravenous infusion

Composition:

Excipient Ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid

Administration route:

Intravenous

Units in package:

1 x 50mL vial

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Trasylol is used prophylactically to reduce perioperative blood loss and to reduce the need for blood transfusion in adult patients undergoing cardiopulmonary bypass in the course of coronary artery bypass graft surgery, where the risk of bleeding is high (impaired haemostasis, eg. presence of aspirin) or where transfusion is unavailable or unacceptable.

Product summary:

Visual Identification: Clear, colourless frothy solution.; Container Type: Vial; Container Material: Glass; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Authorization status:

Registered

Authorization date:

1993-08-02